Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

New nanocarriers improve skin drug delivery with low toxicity at certain concentrations.

Ruxolitinib helped a patient with alopecia areata regrow hair.

A botanical extract may help manage hair loss from chemotherapy by preventing cell death in hair follicles.

MT-DADMe-ImmA can selectively kill head and neck cancer cells without harming normal cells.

Low-intensity ultrasound may prevent hair loss during taxane chemotherapy.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Patients with advanced breast cancer prioritize quality of life, overall survival, and progression-free survival in treatment decisions.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

The treatment is safe and effective for elderly patients with advanced non-small-cell lung cancer.

Multicomponent crystals in microneedles improve drug delivery for hair loss treatment.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Exemestane may protect bones by stimulating osteoblast growth through androgen-related pathways.

Targeting multiple pathways and understanding genetic mutations are crucial for effective melanoma therapy.

Alpha-tocopherol does not prevent hair loss from doxorubicin.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Anti-PD-L1 immunotherapy can cause hair loss and unexpected hair color change, but treatment can restore hair growth and color.

Silver nanoparticles from Mitracarpus scaber protect the liver and reduce prostate enlargement.

Curcumin spanlastics are the most effective for cancer therapy due to their strong antimicrobial, antioxidant, and antitumor effects.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.

Polymeric micelle nanocarriers deliver adapalene more effectively to hair follicles than commercial products.

Lysocellin helps stop cell damage from etoposide and may prevent hair loss.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Cell membrane-coated nanoparticles could improve gene therapy by enhancing delivery and targeting of nucleic acids.

Recombinant Human Annexin A5 may help treat localized scleroderma by reducing skin thickening and inflammation.

Axitinib treatment turned a man's grey hair back to black.

Upadacitinib effectively treats severe alopecia areata and is safe.

Nanoparticle systems make cancer treatment less toxic.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.